Planned Solutions’s Fulgent Genetics FLGT Stock Holding History

Planned Solutions’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-145	Closed	-$8K	–	180
2020 Q4	$8K	Buy	+145	New	+$6.06K	0.01%	339

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Planned Solutions's FLGT Position: Q1 2021 in Review

Planned Solutions sold out of Fulgent Genetics (FLGT) in Q1 2021, closing a stake of 145 shares — an estimated $8K sold.

Planned Solutions first reported a position in FLGT in Q4 2020 and held it in 1 quarter. The position peaked at $8K in Q4 2020. 256 funds tracked by Wall St. Rank hold FLGT as of Q1 2021.

Planned Solutions reported no remaining Fulgent Genetics position as of Q1 2021 after selling out during the quarter.
Planned Solutions sold 145 Fulgent Genetics shares in Q1 2021, an estimated $8K.
Planned Solutions first reported a position in Fulgent Genetics in Q4 2020 and held it in 1 quarter.
Planned Solutions's Fulgent Genetics position peaked at $8K in Q4 2020.
256 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2021.

Based on Planned Solutions's 13F filing for Q1 2021, filed 29 Apr 2021.